The company focuses on three major strategical directions:   global based product development, market to global markets, State-of-The-Art manufacturing.  We   focus on three  major treatment fields: ophthalmology, virus infectious disease and cancer. There are many innovative drug formulations, which have already carried out  R&D and clinical work in China and the United States.

Zennova Pharmaceuticals Group is a high-tech international pharmaceutical group company registered in Cayman and driven by innovative research and development. Powered by leading product development and patented technology , we provide patients with innovative products with superior value. The company focuses on three major strategical directions:global based product development, market to global markets, State-of-The-Art manufacturing.  At present, there are many innovative preparations, and clinical works have been carried out in China and the United States.

At present, Zennova has  research and development centers in New York, USA and Chengdu, China.Zennova’s manufacturing site in Chengdu China is designed and built for qualifying US FDA CGMP ,European EMA certification and China’s GMP qualifications.  This State-of-The-Art facility aims the top global quality standard, and will produce all-dosage drugs  , including a variety of anti-tumor drugs, sterile eye drops, central nervous system drugs and other prescription drugs. All products will be sold to China and the global market.